Funded Tech Companies
Eikon Therapeutics
Wondering who invested in Eikon Therapeutics? Horizons Ventures, Harel Insurance and Hartford HealthCare put venture money into this innovative biopharmaceutical company.
Company Overview
Company Name
Eikon Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
3929 Point Eden Way
Hayward, CA 94545
USA
Hayward, CA 94545
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Eikon Therapeutics is a drug discovery and development company. Our proprietary platform leverages super-resolution microscopy, a Nobel Prize-winning technology, as well as the latest advances in biology, chemistry, engineering, and automation toward the goal of developing and bringing to market novel therapies.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/7/2022
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Roger Perlmutter
Chief Scientific Officer
Daniel Anderson
Company Investors
- Horizons Ventures
- Harel Insurance
- Hartford HealthCare
- Schroder Adveq
- Soros Fund Management
- The Column Group (Larry Lasky)
- General Catalyst Partners
- Innovation Endeavors (Eric Schmidt)
- Foresite Capital
- EcoR1 Capital Management
- Stepstone
- Lux Capital
- E15VC
- Canada Pension Plan Investment Board
- T. Rowe Price (John Hall)
- University of California Investment Office
- Abu Dhabi Investment Authority
- AME Cloud Ventures
Browse more funded tech companies:
Eigner | Eikonoklastes Therapeutics
Share this article
About Our VC Transaction Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs